Regencell Bioscience
Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people’s immune systems.

$316.5M

Market Cap • 4/3/2025

2014

(11 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of HK

Hong Kong

Headquarters